Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Ioxilan is a low-osmolar, nonionic, and tri-iodinated diagnostic contrast agent used for excretory urography and contrast-enhanced computed tomographic (CECT) imaging of the head and body. Intravascularly injected causes opacification of vessels, allowing for radiographic visualization of internal structures until significant hemodilution occurs.
In vitro | The development of Ioxilan incorporates a dual methylene structure to act as a hydrophobic region, which is then concealed by a hydrophilic hydroxyl group. This modification reduces osmolality without compromising biological tolerance. As a low-osmolar, nonionic monomer, Ioxilan enhances the safety and tolerability of X-ray contrast agents. |
In vivo | Rapid intravenous injection of (water-soluble) X-ray contrast agents (Ioxilan), used in conjunction with dynamic computed tomography, enhances the visualization of liver lesions. These agents, primarily remaining in the extracellular fluid and excreted unchanged by the kidneys, distribute effectively post-injection. The degree of contrast enhancement in a specific region is influenced by the administration method, the delivery of the agent via blood flow, and the resultant iodine concentration in that area. |
分子量 | 791.11 |
分子式 | C18H24I3N3O8 |
CAS No. | 107793-72-6 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 250 mg/mL (316.01 mM)
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Ioxilan 107793-72-6 Others Inhibitor inhibitor inhibit